화학요법을 받는 유방암 환자의 인지기능장애 관련 요인
Correlates Influencing Cognitive Impairment in Breast Cancer Patients receiving Chemotherapy
1
조회
0
다운로드
12
인용
0
참고문헌
키워드
초록
Purpose: The purpose of this study was to identify correlates influencing cognitive impairment in breast cancer patients receiving chemotherapy. Methods: Study subjects consisted of 102 breast cancer patients who received chemotherapy. Subjects were the members of a breast cancer self-help group. Data were collected using structured self-reporting questionnaires including scales of cognitive impairment, physical status, fatigue, quality of life, emotional status, sleeping, family support, and menopausal symptoms. Statistical Package for Social Sciences was used for statistical analyses. Results: Breast cancer patients receiving chemotherapy appeared to show a high level of cognitive impairment. Among demographic characteristics, the effects of economic status and family type on cognitive impairment were found to be statistically significant. Among disease related characteristics, the effect of duration of chemotherapy on cognitive impairment was statistically significant. Menopausal symptoms were positively associated with cognitive impairment. The model including postmenopausal symptoms and caregiver type explained about 66% of variability in cognitive impairment. Conclusion: These findings highlight the importance of contextual factors in understanding cognitive impairment in breast cancer patients receiving chemotherapy and can be used to develop appropriate, effective nursing interventions.
Abstract
Purpose: The purpose of this study was to identify correlates influencing cognitive impairment in breast cancer patients receiving chemotherapy. Methods: Study subjects consisted of 102 breast cancer patients who received chemotherapy. Subjects were the members of a breast cancer self-help group. Data were collected using structured self-reporting questionnaires including scales of cognitive impairment, physical status, fatigue, quality of life, emotional status, sleeping, family support, and menopausal symptoms. Statistical Package for Social Sciences was used for statistical analyses. Results: Breast cancer patients receiving chemotherapy appeared to show a high level of cognitive impairment. Among demographic characteristics, the effects of economic status and family type on cognitive impairment were found to be statistically significant. Among disease related characteristics, the effect of duration of chemotherapy on cognitive impairment was statistically significant. Menopausal symptoms were positively associated with cognitive impairment. The model including postmenopausal symptoms and caregiver type explained about 66% of variability in cognitive impairment. Conclusion: These findings highlight the importance of contextual factors in understanding cognitive impairment in breast cancer patients receiving chemotherapy and can be used to develop appropriate, effective nursing interventions.
참고문헌 (26)
- "Breast Cancer Facts & Figures 2011-2012" (2012)[URL]
- "National Cancer Statistics" (2012)[URL]
- Downie FP, "Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving ajuvant chemotherapy: evaluation with patient interview after formal assessment", Psychooncology, 15, pp.921~930 (2006)
- Hess LM, "Chemotherapy-related change in cognitive function: a conceptual model", Oncol Nurs Forum, 34, pp.971~980 (2007)
- 김경혜, "항암화학요법을 받은 유방암 환자의 인지기능", Asian Oncology Nursing, 12(1), pp.1~11 (2012), 대한종양간호학회
- Hurria A, "Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study", J Am Geriatr Soc, 54, pp.925~931 (2006)
- , Utah Univ, 2007
- Falleti MG, "The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women breast cancer: a meta-analysis of the current literature", Brain Cogn, 59, pp.60~70 (2005)
- Biegler KA, "Cancer, cognitive impairment, and meditation", Acta Oncologica, 48, pp.18~26 (2009)
- Bender CM, "Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review", J Pain Symptom Manage, 21, pp.407~424 (2001)
- Ah DV, "Cognitive dysfunction and its relationship to quality of life in breast cancer survivors", Oncol Nurs Forum, 36, pp.326~334 (2009)
- Mehnert A, "The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy", Patient Educ Couns, 66, pp.108~118 (2006)
- Reid-Arndt SA, "The potential for neuropsychology to inform functional outcomes research with breast cancer survivors", Neuro Rehabilitation, 21, pp.51~64 (2006)
- Farias ST, "The measurement of everyday cognition (ECog): Scale development and psychometric properties", Neuropsychology, 22, pp.531~544 (2008)
- Chon MH, "Survey for the side effects of radiation therapy following breast cancer surgery: comparison of modified radical mastectomy and breast conservative surgery", Journal of Research Institute of Korean Medicine, Daejeon University, 5, pp.473~484 (1997)
- 박경순, "방사선치료를 받는 암환자의 급성 부작용과 피로의 변화*", Asian Oncology Nursing, 2(1), pp.72~82 (2002), 대한종양간호학회
- "FACIT-Fatigue scale, version 4 (2007)" (2012)[URL]
- Derogatis LR, "Confirmation of the dimensional structure of the scl-90, a study in construct validation", J Clin Psychol, 33, pp.981~989 (1977)
- Kim GI, "The principle of a brief psychological test" (1984), Jungang Aptitude Institute
- Oh JJ, "Development and validation of Korean sleep scale A", J Korean Acad Nurs, 28, pp.563~572 (1998)
- Neugarten BL, "Age, norm, age constraits and adult socialization", Am J Sociol, 70, pp.710~717 (1965)
- Bark NJ, "Self concept and self-reported climacteric symptoms", pp.1989
- "Functional assessment of cancer therapy (FACT) - breast cancer, version 4 (2007)" (2012)[URL]
- 소희영, "성인의 인지기능 평가에 관한 연구", 성인간호학회지, 16(2), pp.245~255 (2004), 성인간호학회
- O’Shaughnessy J, "Chemotherapy-related cognitive dysfunction in breast cancer", Semin Oncol Nurs, 19, pp.17~24 (2003)
- Jenkins V, "A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer", Br J Cancer, 94, pp.828~834 (2006)
